Arylalkyl-amines and -amides having anticonvulsant and neuroprot

Details Arylalkyl-amines and -amides having anticonvulsant and neuroprot Arylalkyl-amines and -amides having anticonvulsant and neuroprot

1992-07-20

1994-07-19

Hollrah, Glennon H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514626, 514539, 514620, 514649, 558414, 564196, 564337, 560 39, 560 46, A01N 3134, A01N 3712, A01N 3718, A61K 31275

Patent

active

053310071

ABSTRACT:
There is provided a method of treatment of neurological disorders, such as epilepsy, stroke and cerebral ischaemia, which comprises the administration of a compound of Formula I: ##STR1## wherein, Ar.sub.1 and Ar.sub.2, which may be the same or different, independently represent phenyl or phenyl substituted by one or more of amino, nitro, halogen, hydroxy, C1 to 6 alkoxy, C1 to 6 alkyl or cyano;

REFERENCES:
patent: 4309424 (1982-01-01), Martin et al.
patent: 4822914 (1989-04-01), Martin et al.
patent: 4968721 (1990-11-01), Martin et al.
patent: 5093524 (1992-03-01), Griffith
Martin et al., "Carboxamides of Therapeutic Value", (1957) CA 53, 6154(c) (1959).
CA 64,14162f, abstracting Zaheer et al., Ann. Chem. 691, 55.60 (1966).
CA 73,25044n, abstracting Novelli et al., Bol. Soc. Quim Peru 35(3), 77-84 (1969).
CA 77,19586g, abstracting Patel et al., J. Indian Chem. Soc. 49(2), 177-180 (1972).
CA 85,5705y, abstracting Japan Kokai 50/130776 (1975).
CA 96,19744z, abstracting Antoniadau-Vyza et al., Prakt. Akad. Athenon 54(A-B), 383-397 (1980).
J. C. Hubsch et al., "Determination of 2-Amino-N(1-Methyl-1,2-Diphenylethyl) Acetamide Monohydrochloride From a Ground Beef Matrix b High Performance Liquid Chromatography", Abst. 127, Northeast Regional Meeting of the Am. Chem. Soc., Rochester, N.Y., Nov. 19, 1987.
G. C. Palmer et al., "A New Anticonvulsanat, PR 934-423 Active Against Maximal Electroshock Seizures I: Mice Studies", Abst. 317.15 Society of Neuroscience Meetings, (Nov. 16, 1987).
P. M. Colombo et al., "A New Anticonvulsant, PR 934-423, Active Against Maximal Electroshock Seizures II: Rat Studies". Abst. 317.16, Society of Neuroscience Meetings, La. (Nov. 16, 1987).
L. R. Freedman et al., "A New Anticonvulsant, PR 934-423, Active Against Maximal Electroshock Seizures, III: Electrophysiological Studies". Abst. 317.17, Society of Neuroscience Meetings, New Orleans, La. (Nov. 16, 1987).
C. F. Luke et al., "Toxicity of a Novel Anticonvulsant, 2-Amino-N-(2-Methyl-1,2-Diphenylethyl)Acetamide, PR 934-423A". Abst. Society of Toxicology Annual Meeting, Dallas, Tex. (Feb. 15, 1988).
Griffith et al., "Synthesis and Anticonvulsant Activity of a Series of 2-Amino-N-(1,2-Diphenylethyl)acetamides". Abst. 196th Natl. Meeting of the Am. Chem. Society, Los Angeles, Calif. (Sep. 25-29, 1988).
Garske et al., "Preclinical Profile of Isomers of the Anticonvulsant PR 934-423". Society of Neuroscience Meeting, Toronto, Ont., Can. (Nov. 1988).
Stagnitto et al., "PR 1013-708, A Potent Anticonvulsant Against Maximal Electroshock. Seizures (MES) in Rodents". Abst. Society of Neuroscience Meeting, Toronto, Ont. Can. (Nov. 1988).
Wilson et al., "Anticonvulsant Concentrations in SCF and Serum of Rats Protected Against MES by PR 934-423A". Abst. Society of Neuroscience Meeting, Toronto, Ont., Can. (Nov. 1988).
Palmer et al., "Status of PR 934-423. A Novel Anticonvulsant Targeted for Generalized Toxic/Clinic Seizures (New Designation is FPL 12924AA". Abstract. Princeton Symposium, N.J. (May 1989).
Gosh et al., Arzneim-Forch./Drug Res. 28 (11) Heft 9 (1978) pp. 1561-1564 disclose a series of 1,2-diphenylethylamines as potential non-stimulant anorectics.
Winn et al., J. Org. Chem., 33 (6), 2388-92 (1968) disclose the preparation of pyridinylalkylamines. No biological activity is disclosed.
CA 84(9):59216n, abstracting German Offen. DE 2415063 (1976), describes the preparation of pyridinylalkylamidines from pyridylalkylamines.
CA 104(17):148472s, abstracting U.S. Pat. No. 4,536,599, discloses diphenylalkylamines which are useful as pharmaceutical intermediates and optical resolution agents (1986).

Affiliated with

Also associated with

Rating

Arylalkyl-amines and -amides having anticonvulsant and neuroprot does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylalkyl-amines and -amides having anticonvulsant and neuroprot, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylalkyl-amines and -amides having anticonvulsant and neuroprot will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-520356